Payer Coverage Policies for Multigene Tests

Nature Biotechnology - United Kingdom
doi 10.1038/nbt.3912
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Coverage-Based Test Cases Selection for XACML Policies

2014English

An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers

Frontiers in Medicine
Medicine
2018English

Medicaid Coverage of Screening Tests for Breast and Cervical Cancer.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1992English

Measuring Test Properties Coverage for Evaluating UML/OCL Model-Based Tests

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
2011English

Ac2 - Use of Medicine Pricing and Reimbursement Policies for Universal Health Coverage in Indonesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Influenza A(H1N1)pdm09 Vaccination Policies and Coverage in Europe

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2012English

Pcn206 - Anaplastic Lymphoma Kinase (Alk) Testing in Non-Small Cell Lung Carcinoma (Nsclc): Recommended Tests and Coverage Policies Across Organisation for Economic Co-Operation and Development (Oecd) Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Multigene Sets for Clinical Application in Glioma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Novel Oral Anticoagulant Use in the Eu5: How Are Payer Policies and Physician Preferences Shaping the Prescribing Landscape?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy